{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:54:48Z","timestamp":1789779288347,"version":"4.0.1"},"reference-count":52,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The objective of this study was to compare the effects of bisphosphonates and denosumab on sarcopenia-related parameters, contributing to a better understanding of osteosarcopenia management. Methods: This cross-sectional, comparative study assessed physical performance, muscle strength, muscle mass, and sarcopenia category in postmenopausal women aged 65 to 80 years with osteoporosis who were receiving either bisphosphonates or denosumab. Additional groups consisted of untreated osteoporotic patients and controls without osteoporosis (n = 50 per group). Muscle mass was assessed using bioelectrical impedance analysis, and the classification of sarcopenia was assessed according to the EWGSOP2 criteria. Results: Among the osteoporotic groups, the 4 m walking speed, 5-chair stand test, and timed up-and-go performance did not differ significantly, although denosumab-treated patients had numerically shorter completion times. Nondominant handgrip strength was the only grip parameter showing a significant between-group difference (p = 0.026), mainly due to higher values in denosumab-treated patients than in untreated osteoporotic patients; dominant and maximum handgrip strength were comparable. Skeletal muscle mass was higher in the denosumab group than in both the bisphosphonate-treated and untreated osteoporosis groups (p = 0.045), whereas ALM, ASM, and the ASMI did not differ significantly. No statistically significant between-group differences were observed in SARC-F scores or sarcopenia classifications. Controls had significantly higher odds of sarcopenia absence compared with untreated osteoporotic patients, and treatment duration was not correlated with sarcopenia-related parameters. Conclusions: These findings suggest a favorable but limited association between denosumab treatment and selected muscle-related parameters. Prospective longitudinal studies are needed to determine whether anti-osteoporotic therapies influence osteosarcopenia.<\/jats:p>","DOI":"10.3390\/jcm15135010","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"5010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Denosumab and Bisphosphonates for Sarcopenia in Postmenopausal Osteoporosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-6666","authenticated-orcid":false,"given":"Seda Karaaslan","family":"Yetemen","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-9513","authenticated-orcid":false,"given":"Erhan","family":"Hocaoglu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-6608","authenticated-orcid":false,"given":"Erdinc","family":"Erturk","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"101934","DOI":"10.1016\/j.arr.2023.101934","article-title":"60 Years of Healthy Aging: On Definitions, Biomarkers, Scores and Challenges","volume":"88","author":"Behr","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/jcp.25001","article-title":"Determinants of Muscle and Bone Aging","volume":"230","author":"Curtis","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jcsm.12567","article-title":"Osteosarcopenia: Epidemiology, Diagnosis, and Treatment\u2014Facts and Numbers","volume":"11","author":"Kirk","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/keaa755","article-title":"Osteosarcopenia: Where Osteoporosis and Sarcopenia Collide","volume":"60","author":"Clynes","year":"2021","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Huang, T., Li, C., Chen, F., Xie, D., Yang, C., Chen, Y., Wang, J., Li, J., and Zheng, F. (2023). Prevalence and Risk Factors of Osteosarcopenia: A Systematic Review and Meta-Analysis. BMC Geriatr., 23.","DOI":"10.1186\/s12877-023-04085-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jcb.25040","article-title":"Interactions Between Muscle Tissues and Bone Metabolism","volume":"116","author":"Kawao","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","article-title":"Osteosarcopenia: Where Bone, Muscle, and Fat Collide","volume":"28","author":"Hirschfeld","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine Regulation of Energy Metabolism by the Skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S8756-3282(96)00138-X","article-title":"Growth Factors for Bone Growth and Repair: IGF, TGF\u03b2 and BMP","volume":"19","author":"Linkhart","year":"1996","journal-title":"Bone"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Maurel, D., J\u00e4hn, K., and Lara-Castillo, N. (2017). Muscle\u2013Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies. Biomedicines, 5.","DOI":"10.3390\/biomedicines5040062"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1097\/MS9.0000000000001352","article-title":"Potential Application of Anti-Osteoporotic Therapy to Relieve Sarcopenia in the Elderly","volume":"85","author":"Li","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European Consensus on Definition and Diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cohen, J. (2013). Statistical Power Analysis for the Behavioral Sciences, Routledge. [2nd ed.].","DOI":"10.4324\/9780203771587"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1759720X14546350","article-title":"Medication-Induced Osteoporosis: Screening and Treatment Strategies","volume":"6","author":"Panday","year":"2014","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jbmr.4335","article-title":"Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases","volume":"36","author":"Burckhardt","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/jbmr.3654","article-title":"Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials","volume":"34","author":"Kim","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_20","unstructured":"FRAXplus\u00ae (2024, May 20). FRAX\u00ae Fracture Risk Assessment Tool. Available online: https:\/\/www.fraxplus.org\/calculation-tool."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: A Symptom Score to Predict Persons with Sarcopenia at Risk for Poor Functional Outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2010.1923","article-title":"Gait Speed and Survival in Older Adults","volume":"305","author":"Studenski","year":"2011","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1532-5415.2008.02126.x","article-title":"Added Value of Physical Performance Measures in Predicting Adverse Health-Related Events: Results from the Health, Aging and Body Composition Study","volume":"57","author":"Cesari","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12603-009-0246-z","article-title":"Gait Speed at Usual Pace as a Predictor of Adverse Outcomes in Community-Dwelling Older People an International Academy on Nutrition and Aging (IANA) Task Force","volume":"13","author":"Rolland","year":"2009","journal-title":"J. Nutr. Health Aging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ageing\/32.3.315","article-title":"Identifying a Cut-off Point for Normal Mobility: A Comparison of the Timed \u201cup and Go\u201d Test in Community-Dwelling and Institutionalised Elderly Women","volume":"32","author":"Bischoff","year":"2003","journal-title":"Age Ageing"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jcsm.12732","article-title":"Validating Muscle Mass Cutoffs of Four International Sarcopenia-working Groups in Japanese People Using DXA and BIA","volume":"12","author":"Yamada","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.clnu.2016.02.002","article-title":"Cut-off Points to Identify Sarcopenia According to European Working Group on Sarcopenia in Older People (EWGSOP) Definition","volume":"35","author":"Bahat","year":"2016","journal-title":"Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104517","DOI":"10.1016\/j.archger.2021.104517","article-title":"Which Is the Best Alternative to Estimate Muscle Mass for Sarcopenia Diagnosis When DXA Is Unavailable?","volume":"97","author":"Barros","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"van den Helder, J., Verreijen, A.M., van Dronkelaar, C., Memelink, R.G., Engberink, M.F., Engelbert, R.H.H., Weijs, P.J.M., and Tieland, M. (2022). Bio-Electrical Impedance Analysis: A Valid Assessment Tool for Diagnosis of Low Appendicular Lean Mass in Older Adults?. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.874980"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","article-title":"Bioelectrical Impedance Analysis\u2014Part II: Utilization in Clinical Practice","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL Inhibition Improves Muscle Strength and Insulin Sensitivity and Restores Bone Mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/DDDT.S328858","article-title":"Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"420","DOI":"10.14283\/jfa.2022.54","article-title":"Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial","volume":"11","author":"Haeri","year":"2022","journal-title":"J. Frailty Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11657-024-01475-3","article-title":"Effects of Denosumab and Zoledronic Acid on Postmenopausal Osteoporosis, Bone Density, and Fat-Free Mass","volume":"20","author":"Ha","year":"2025","journal-title":"Arch. Osteoporos."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ajpath.2015.01.006","article-title":"Osteoprotegerin Protects against Muscular Dystrophy","volume":"185","author":"Dufresne","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11657-020-00835-z","article-title":"Decreased Lower-Extremity Muscle Performance Is Associated with Decreased Hip Bone Mineral Density and Increased Estimated Fracture Risk in Community-Dwelling Postmenopausal Women","volume":"15","author":"Dai","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.1038\/s41598-021-93483-3","article-title":"Differences in the Level of Physical Fitness and Mobility among Older Women with Osteoporosis and Healthy Women\u2014Cross-Sectional Study","volume":"11","author":"Babiuch","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Park, H.J., Han, B., Chang, S., Kang, S.H., Lee, D.W., and Kang, S. (2023). Hand Grip Strength, Osteoporosis, and Quality of Life in Middle-Aged and Older Adults. Medicina, 59.","DOI":"10.3390\/medicina59122148"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Tarantino, U., Greggi, C., Visconti, V.V., Cariati, I., Tallarico, M., Fauceglia, M., Iundusi, R., Albanese, M., Chiaramonte, C., and Gasbarra, E. (2021). T-Score and Handgrip Strength Association for the Diagnosis of Osteosarcopenia: A Systematic Review and Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122597"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.31616\/asj.2018.12.5.839","article-title":"Use of Bioelectrical Impedance Analysis for the Measurement of Appendicular Skeletal Muscle Mass\/Whole Fat Mass and Its Relevance in Assessing Osteoporosis among Patients with Low Back Pain: A Comparative Analysis Using Dual X-Ray Absorptiometry","volume":"12","author":"Fujimoto","year":"2018","journal-title":"Asian Spine J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.14310\/horm.2002.1732","article-title":"Bioimpedance Analysis vs. DEXA as a Screening Tool for Osteosarcopenia in Lean, Overweight and Obese Caucasian Postmenopausal Females","volume":"16","author":"Peppa","year":"2017","journal-title":"Hormones"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/os.12701","article-title":"Fall Prevention and Anti-Osteoporosis in Osteopenia Patients of 80\u2009Years of Age and Older: A Randomized Controlled Study","volume":"12","author":"Zhou","year":"2020","journal-title":"Orthop. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0031-1296166","article-title":"Risk Reduction of Falls and Fractures, Reduction of Back Pain and Safety in Elderly High Risk Patients Receiving Combined Therapy with Alfacalcidol and Alendronate: A Prospective Study","volume":"61","author":"Schacht","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1007\/s10067-021-05757-w","article-title":"Is There a Potential Dual Effect of Denosumab for Treatment of Osteoporosis and Sarcopenia?","volume":"40","author":"Miedany","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1111\/jgs.16165","article-title":"Effect of Denosumab on Falls, Muscle Strength, and Function in Community-Dwelling Older Adults","volume":"67","author":"Phu","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00198-022-06470-3","article-title":"Beneficial Effects of Denosumab on Muscle Performance in Patients with Low BMD: A Retrospective, Propensity Score-Matched Study","volume":"33","author":"Rupp","year":"2022","journal-title":"Osteoporos. Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11845-019-02086-5","article-title":"May Zoledronic Acid Have Negative Effects on Cognition and Muscle Performance?","volume":"189","author":"Turgut","year":"2020","journal-title":"Ir. J. Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/GME.0b013e31827cabca","article-title":"Concomitant Increase in Muscle Strength and Bone Mineral Density with Decreasing IL-6 Levels after Combination Therapy with Alendronate and Calcitriol in Postmenopausal Women","volume":"20","author":"Park","year":"2013","journal-title":"Menopause"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.afos.2015.07.005","article-title":"Effect of Alendronate on Muscle Mass: Investigation in Patients with Osteoporosis","volume":"1","author":"Harada","year":"2015","journal-title":"Osteoporos. Sarcopenia"},{"key":"ref_50","first-page":"92","article-title":"Effects of Antiresorptive Agents on Body Composition: A Case-Control Retrospective Study","volume":"61","author":"Fogliame","year":"2023","journal-title":"Reumatologia"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Pizzonia, M., Casabella, A., Natali, M., Petrocchi, L., Carmisciano, L., Nencioni, A., Molfetta, L., Giannotti, C., Bianchi, G., and Giusti, A. (2021). Osteosarcopenia in Very Old Age Adults After Hip Fracture: A Real-World Therapeutic Standpoint. Front. Med., 8.","DOI":"10.3389\/fmed.2021.612506"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00198-018-4460-6","article-title":"Effects of Discontinuing Oral Bisphosphonate Treatments for Postmenopausal Osteoporosis on Bone Turnover Markers and Bone Density","volume":"29","author":"Naylor","year":"2018","journal-title":"Osteoporos. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:48:52Z","timestamp":1782726532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/5010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":52,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15135010"],"URL":"https:\/\/doi.org\/10.3390\/jcm15135010","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}